Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Current Leases: 2021-2024

Historic Current Leases for Capricor Therapeutics (CAPR) over the last 4 years, with Dec 2024 value amounting to $834,799.

  • Capricor Therapeutics' Current Leases fell 85.24% to $120,094 in Q3 2025 from the same period last year, while for Sep 2025 it was $120,094, marking a year-over-year decrease of 85.24%. This contributed to the annual value of $834,799 for FY2024, which is 11.44% up from last year.
  • According to the latest figures from FY2024, Capricor Therapeutics' Current Leases is $834,799, which was up 11.44% from $749,112 recorded in FY2023.
  • In the past 5 years, Capricor Therapeutics' Current Leases ranged from a high of $834,799 in FY2024 and a low of $417,632 during FY2021.
  • Moreover, its 3-year median value for Current Leases was $749,112 (2023), whereas its average is $755,317.
  • Data for Capricor Therapeutics' Current Leases shows a peak YoY soared of 63.31% (in 2022) over the last 5 years.
  • Yearly analysis of 4 years shows Capricor Therapeutics' Current Leases stood at $417,632 in 2021, then spiked by 63.31% to $682,039 in 2022, then grew by 9.83% to $749,112 in 2023, then rose by 11.44% to $834,799 in 2024.